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Background/aim: Hantavirus is a rodent borne zoonosis caused by the members of the virus family Bunyaviridae, genus Hantavirus. In
this study, we aimed to determine the role of peripheral blood leukocyte ratio in differential diagnosis of Hantavirus disease.
Materials and methods: The medical records of patients at the Düzce University Medical Faculty were examined retrospectively. A
total of 20 patients diagnosed with hantavirus infection confirmed by serologic tests were included in the study (Group 1). The other
group consisted of 30 patients suspected of hantavirus infection but found negative (Group 2). Demographic, clinical and laboratory
characteristics, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and lymphocyte/monocyte (LMR) ratios of both
groups were compared.
Results: As a result of the istatistics analysis, no difference was found between the groups’ age, sex, and clinical complaints except
lethargy-weakness (P = 0.004) and diarrhea (P < 0.001). Hemogram analysis showed a significant difference between the groups in
terms of leukocyte, hemoglobin, hematocrit, platelet, mean platelet volume (P < 0.05) and PLR (P = 0.001) and LMR (P = 0.003) values
from peripheral blood leukocyte ratios.
Conclusion: In conclusion, NLR, PLR, and LMR ratios may be useful for clinicians in differential diagnosis of Hantavirus in patients
presenting with similar symptoms of Hantavirus disease.
Key words: Hantaviruses, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (PLR),
predictive factors, Turkey

1. Introduction
Hantaviruses, a member of the family Bunyaviridae, cause
two known zoonotic infections: hemorrhagic fever with
renal syndrome (HFRS) and hantavirus cardiopulmonary
syndrome (HCPS) [1]. The hantavirus reservoirs in nature
consist of various rodents and insectivores. In rodents,
the infection is frequently asymptomatic or progresses
in the form of chronic carriage. Transmission to humans
occurs through respiration of aerosols contaminated with
the urine, saliva, and pulmonary secretions of infected
rodents [2]. HCPS leads to manifestations of diffuse
pulmonary edema, impaired pulmonary functions,
and cardiovascular failure, and mortality is high. This
syndrome frequently occurs with the Sin Nombre, Andes,
Laguna Negra and New York serotypes is widely reported
on the American continent and attracted particular

attention with an outbreak in 1993 [3,4]. HFRS is a disease
type that generally occurs in Europe and Asia and deriving
from the Dobrova, Puumala, Hantaan, Saaremaa, and
Seoul serotypes. Depending on the virus serotype, the
disease may range from mild to severe form. The Puumala
serotype has quite low mortality [5,6]. Hantavirus was
first identified in Turkey in the Black Sea region in 2009 in
patients presenting with fever, abdominal pain, diarrhea,
thrombocytopenia, and renal insufficiency. Hantavirus
cases were subsequently reported from various Black Sea
region provinces [7–9]. The principal laboratory findings
in these cases, generally seen in the form of HFRS, are
thrombocytopenia and creatinine elevation. Similar
to other critical illnesses, identifying early and novel
biomarkers and combining clinical features with laboratory
parameters for predicting diagnosis and prognosis of
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hantavirus will be of great assistance to clinicians in terms
of initiating effective treatment and improving success
rates.
Peripheral blood leucocyte ratios are an important
parameter that has begun being used in patients with
infectious diseases in recent years. Several studies have
revealed that these are useful in evaluating the etiology,
course, and prognosis of such diseases [10,11]. These
include the neutrophil-to-lymphocyte ration (NLR), the
platelet-to-lymphocyte ratio (PLR), and the lymphocyteto-monocyte ratio (LMR). This study compared the
demographic data, clinical features, and laboratory values
of patients presenting from Düzce and the surrounding
area to our hospital in the Western Black Sea region in
2012–2018 and with confirmed or suspected hantavirus
infection. This is also the first study to evaluate peripheral
blood leucocyte ratios in the context of predicting
diagnosis of hantavirus infection.
2. Materials and methods
2. 1. Study design
The medical records of patients under follow-up and
treatment with a preliminary diagnosis of hantavirus
infection at the Düzce University Medical Faculty, Turkey,
in 2012-2018 were examined retrospectively. Twenty
patients diagnosed with hantavirus infection confirmed
by serologic tests were included in the study (Group
1). The other group consisted of 30 patients suspected
of hantavirus infection but found negative (Group 2).
This group consisted of patients who were considered as
suspected cases due to the initial complaints and similar
regions. Group 2 patients were discharged with different
diagnosis from nonspecific infection (respiratory system,
gastrointestinal tract infection etc.) or noninfection
during the follow-up period. Group 2 was composed of
patients who had negative serological tests both in the
initial application and in the serum samples taken on the
following days.
The demographic and clinical characteristics
and laboratory parameters obtained at time of initial
presentation of 20 patients with positive laboratory
hantavirus diagnosis and 30 patients with negative
findings following preliminary diagnosis were recorded.
Patients’ demographic characteristics, age, sex,
occupation, length of incubation, length of hospital stay,
clinical findings, blood values (white blood cell [WBC],
platelet count [PLT], hematocrit [Hct], hemoglobin [Hb],
mean platelet volume [MPV], aspartate aminotransferase
[AST], alanine aminotransferase [ALT], total bilirubin,
lactate dehydrogenase [LDH], alkaline phosphatase
[ALP], creatine phosphokinase [CPK], C-reactive protein
[CRP], creatinine [Cr], prothrombin time [PT], activated
partial thromboplastin time [aPTT], and international

normalized ratio [INR]) were recorded onto forms. NLR,
PLR, and LMR were calculated as the ratio of neutrophils
to lymphocytes, platelets to lymphocytes, and monocytes
to lymphocytes, respectively. These parameters were
compared between the groups 1 and 2.
2.2. Laboratory methods
Complete blood count parameters were measured by an
automated hematology analyzer (Abbott Cell-Dyn Ruby;
IL 60064 USA). CRP was measured from blood samples
using turbidimetry (Uni Cel RDxC 800; Beckman Coulter,
Pasadena, CA, USA).
For diagnosis of hantavirus infection, patients’
serum samples were sent to the National Arboviruses
and Viral Zoonoses Laboratory, Microbiology Reference
Laboratories and Biological Products Department of the
Turkish Public Health General Directorate. The indirect
immunofluorescence test (Hantavirus Mosaic 1, IIFT,
immunoglobulin G [IgG] and IgM, Euroimmun, Perkin
Elmer, USA) was used for serological diagnosis. The
presence of antihantavirus antibodies against HTNV, Sin
Nombre, PUUV, DOBV, SEOV, and Saaremaa viruses
were assessed in line with the manufacturer’s instructions
with 100-fold dilution. All positive samples were retested
with Euroline Hantavirus Profile 1 Immunoblot testing
(Euroimmun, Perkin Elmer, USA) in order to differentiate
between different serotypes.
2.3. Statistical analysis
Distribution of data was examined using the Shapiro–
Wilk test. The independent samples t test was used to
compare normally distributed data between the groups,
while the Mann-Whitney U test was used for data with
nonnormal distribution. Pearson’s chi-square, Fisher’s
Exact or Fisher-Freeman-Halton tests were used to
analyze categorical data according to expected count
and number of groups compared. Cut-off values for
discriminating hantavirus positivity were calculated using
receiver operating characteristic (ROC) curve analysis for
statistically significant variables at univariate analyses.
Statistical analyses were performed on SPSS v.22 software
(IBM Corp., Armonk, NY, USA), and P values less than
0.05 were considered significant.
3. Results
3.1. Demographic data and clinical presentation
Mean ages were 38.6 ± 12 years in Group 1 and 45.2 ±
20 in Group 2. Men represented 95% (n: 19) of patients
in Group 1 and 76.7% (n: 23) of Group 2. There was no
significant difference between the groups in terms of sex
or age (P > 0.05). Seventeen of the 20 patients followedup with hantavirus positivity lived in the region of
Düzce (13 in the district of Yığılca), while the other three
lived in neighboring provinces. Originating from the
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Yığılca area of Düzce was identified as a risk factor for
hantavirus positivity (P = 0.047). Apart from one patient
who died from acute respiratory syndrome and cardiac
arrest without renal involvement, the other patients with
hantavirus infections were followed-up with a diagnosis
of HFRS, and five patients (25%) received hemodialysis.
Times between onset of symptoms and hospitalization
were not significantly different between the groups 1 and 2,
but the length of hospitalization was significantly greater in
Group 1 (P = 0.003). Comparison of clinical symptoms at
time of initial presentation revealed significant differences
between the groups in terms of lethargy-malaise (P =
0.004) and diarrhea-abdominal pain (P < 0.001). There
was no significant difference in other symptoms. The
most common serotype among patients with hantavirus
infection was Puumala (n: 18). Hantavirus serotype of one
patient who died and five patients who received dialysis
treatment were Puumala. All suspected cases of hantavirus
infection were also screened for acute leptospirosis and
CCHF virus using molecular and serological tests and were
determined to be negative for both agents. The findings are
shown in Table 1.

3.2. Laboratory results
Comparison of blood tests at time of presentation
among patients in the groups 1 and 2 revealed significant
differences in terms of the complete blood count parameters
WBC, Hb, Hct, PLT, and MPV values, and the biochemical
parameters Cr, LDH, and ALP values (P < 0.05). CPK,
hepatic enzymes, total bilirubin, CRP, PT, aPTT, and INR
values were similar between the two groups (P > 0.05).
Mean PLR and LMR values were significantly lower in
patients with hantavirus infection (P = 0.001, and P = 0.003,
respectively). In contrast, NLR was of no diagnostic value
in predicting hantavirus infection (P = 0.289). A statistical
analysis of all parameters is shown in Table 2.
ROC analysis with AUC measurement was used to
explore the predictive value of the laboratory parameters.
This yielded AUC values of 0.836 for WBC, 0.786 for Hb,
0.778 for Hct, 0.763 for Plt, 0.747 for MPV, 0.850 for PLR,
0.747 for LMR, 0.730 for cr, 0.773 for LDH, and 0.793
for ALP (Table 3). ROC analysis of these parameters is
given in three separate charts for complete blood count,
biochemistry, and peripheral blood leucocyte ratios in
Table 3 and the Figures 1, 2, and 3.

Table 1. Demographic and clinic characteristics of the two groups.
Demographic data
Age (years)

38.6 ± 12.1

45.2 ± 20.2

0.155

Sex (male/female)

19/1

23/7

0.123

Place of residence
Düzce-Yığılca (n)
Düzce-other
Other

13 (65%)
4 (20%)
3 (15%)

12 (40%)
16 (53.3%)
2 (6.7%)

0.047

Time between onset of symptoms and hospitalization
(days) mean (min-max)

5 (1-14)

3.5 (0-10)

0.116

Length of hospitalization (days) mean (min-max)

11.5 (2-23)

6 (0-23)

0.003

Hemodialysis

5 (25%)

-

Ex

1 (5%)

-

Clinical findings
Fever
Lethargy-weakness
Nausea-vomiting
Lumbar/back pain
Oliguria/anuria
Burning/itching in the eyes
Shock

15 (75%)
15 (75%)
12 (60%)
13 (65%)
1 (5%)
3 (15%)
1 (5%)

17 (56.7%)
10 (33.3%)
15 (50%)
2 (6.7%)
0 (0%)
2 (6.7%)
0 (0%)

Hantavirus serotype
PUUV
Undifferentiated

18
2

-

PUUV: Puumala virus.
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0.186
0.004
0.487
0.001
0.400
0.636
0,400
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Table 2. Laboratory values of the two groups.
Group 1
(Hantavirus confirmed cases)
n = 20

Group 2
(Hantavirus unconfirmed cases)
n = 30

WBC (µL-1) mean (min-max) (n = 3–15)

12.520 (2100-29.400)

6,900 (900–16,700)

<0.001

Hgb (g/dL) (n = 8-17)

14.4 ± 2.4

11.7±2.4

<0.001

Hct (n = 26–50)

42.5 ± 6.9

34.8 ± 6.8

<0.001

Platelet count (µL ) (min–max) (n = 50-500)

63,500 (10,400–195,000)

131,500 (8000–479,000)

0.002

MPV (n = 9-13)

9.9 ± 1.5

8.7 ± 1.1

0.001

NLR

4.3 (0.5–10.9)

3.1 (0.2–26.4)

0.289

PLR

29.6 (5.9–140.9)

109 (7.3–575)

<0.001

LMR

1.4 (0.7–118.6)

3.4 (0.7–21.5)

0.003

PT (s) (n = 11-15)

13.3 ± 3

12.4 ± 1.4

0.233

aPTT (s) (n = 21-35)

29.4 ± 8.7

27.2 ± 4.0

0.311

INR (n = 0.8–1.2)

1.1 ± 0.1

1.1 ± 0.1

0.560

Urea (mg/dL) (n = 17–43)

89 (14.4–291)

37.7 (12.0–293.1)

0.067

Creatinine (mg/dL) (n = 0.7–1.2)

3.4 (0.7–10.2)

1.2 (0.3–13.4)

0.006

CPK (U/L) (n = 0–171)

234.5 (19–2590)

126 (18–2360)

0.471

LDH (U/L) (n = 135–225)

473.5 ± 175.8

313.9 ± 136.9

0.001

AST (U/L) (n = 0–50)

59 (10–174.3)

38.5 (9–203)

0.488

ALT (U/L) (n = 0–41)

28 (6.4–133)

25.5 (2.5–166.7)

0.692

Bilirubin (mg/dL) (n = 0.3–1.2)

0.4 (0.2–12)

0.5 (0.1–18.6)

0.329

ALP (U/L) (n = 30–120)

59 (30–93)

80.5 (39–150)

0.001

Albumin (g/dL) (n = 3.5–5.2)

3.2 ± 0.5

3.5 ± 0.8

0.165

CRP (mg/dL) (n = 0–5)

7.3 (0.8–16.3)

5.3 (0.1–38.6)

0.699

P-value

Hematological parameters

-1

Biochemical parameters

WBC: white blood cell; Hgb: Hemoglobin, Hct: hematocrit; MPV: mean platelet volume; NLR: neutrophil to lymphocyte ratio, PLR:
Platelet to lymphocyte ratio, LMR: Lymphocyte to monocyte ratio.
CPK: creatinine phosphokinase; LDH: lactate dehydrogenase; AST: aspartate transaminase; ALT: alanine transaminase; AL: alkaline
phosphatase; PT: prothrombin time; aPTT: partial thromboplastin time; INR: international normalized ratio; CRP: C-reactive protein.

Subanalysis of patients receiving and not receiving
dialysis therapy in the hantavirus-positive group revealed
a longer length of hospitalization in subjects undergoing
dialysis (P = 0.033). The subanalysis results revealed no
statistically significant difference in laboratory parameters
or NLR, PLR, and LMR values between the dialysis and
nondialysis (P > 0.05).
4. Discussion
Hantavirus affects tens of thousands of people in Asia and
Europe, and has been reported from different regions of
Turkey in the form of sporadic outbreaks since 2009. The
majority of reported cases originate from the Black Sea
region, a heavily forested area in the north of the country
[7-9,12]. The Düzce region lies in northwest Turkey,

largely between the 41st and 42nd north latitudes. The
fact that most of our patients came from the area of Yığılca
was statistically significant for hantavirus positivity.
In addition to the geographical nature of Yığılca, this
may also be due to homes being within the forest zone,
inadequate socioeconomical conditions, insufficient
hygiene conditions, and an ongoing hantavirus epidemic
in the area.
Initial findings of Hantavirus infection may be
confused with clinical and laboratory findings of other
zoonotic infections. In a recently published article, some
laboratory parameters were compared and a scoring
system was established to differentiate between hantavirus
and leptospirosis [13]. We performed a similar study using
Hemogram parameters in patients with a prediagnosis
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Table 3. Receiver operating characteristics (ROC) analysis for the calculation of the discriminative ability of laboratory
markers.
AUC

95%CI

P value

Cut–off

Sensitivity

Specificity

KR

0.730

0.583–0.877

0.006

≥ 1.88

80.0

76.7

LDH

0.773

0.637–0.910

0.002

≥ 369.5

73.7

71.4

ALP

0.793

0.664–0.922

0.001

≤ 66.5

78.9

76.7

WBC

0.836

0.718–0.954

< 0.001

≥ 8550

80.0

73.3

HB

0.786

0.661–0.910

0.001

≥ 12.6

85.0

66.7

HCT

0.778

0.651–0.905

0.001

≥ 37.45

85.0

66.7

PLT

0.763

0.631–0.894

0.002

≤ 84500

70.0

63.3

MPV

0.747

0.597–0.898

0.003

≥ 9.25

70.0

73.3

PLR

0.850

0.740–0.960

< 0.001

≤ 70.16

85.0

80.0

LMR

0.747

0.594–0.899

0.003

≤ 1.8

70.0

80.0

Figure 1. ROC curves for prediction of hantavirus positivity by WBC, Hb, Hct, Plt, and
MPV.

of Hantavirus. Clinical and laboratory data at time of
presentation to hospital were recorded for hantaviruspositive patients and for patients identified as hantavirusnegative following admission with a preliminary diagnosis
of hantavirus infection. Differences between the two
groups in terms of demographic, clinical, and laboratory
parameters were then examined. We also analyzed
differences between the hantavirus-positive and –negative
groups in terms of the peripheral blood leucocyte ratios
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NLR, PLR and LMR, described as being predictive of
systemic inflammation in several studies.
Demographic characteristics of the hantaviruspositive patients in this study (male 95%, mean age 38.6
years) were consistent with Black Sea region outbreaks
(male 87.5%, mean age 45.9 years) [14] as well as with
outbreaks in other European countries [15]. Although
hantavirus infection is independent of age and sex, the
higher prevalence in males may be attributed to greater

İNCE et al. / Turk J Med Sci

Figure 2. ROC curves for prediction of hantavirus positivity by PLR and LMR.

Figure 3. ROC curves for prediction of hantavirus positivity by cr, LDH, and ALP.
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participation in outdoor activities. The most common
clinical symptoms in our cases (fever, malaise, nauseavomiting, and back pain) were consistent with previous
reports from Germany, Bulgaria, and Slovenia [16-18].
Since 90% of our hantavirus-positive cases involved the
Puumala serotype, no symptoms of shock or hematuria
were determined. The Puumala serotype was also the agent
identified in a neighboring region in 2009 [7]. Significant
differences were observed between groups 1 and 2 in
terms of lethargy and flank pain but none in terms of
other symptoms. Length of hospital stay of the hantaviruspositive patients in our study was similar to that in Çelebi
et al.’s study [14]. Additionally, length of stay was greater
in the hantavirus-positive group than in the hantavirusnegative group.
Leukocytosis and thrombocytopenia are known to
occur in hantavirus infections [2]. Lysis of megakaryocytes
resulting from accumulation of immune complexes
associated with hantavirus and depletion of platelets due
to vascular damage are responsible for the development of
thrombocytopenia [19,20]. Consistent with the previous
literature, leucocyte, hemoglobin and hematocrit values
were higher in the hantavirus-positive group than in the
hantavirus-negative group, while platelet levels were lower.
Wang et al. [21] also reported a relation between platelet
suppression and severity of renal injury. We determined
no significant relation between low platelet values and
dialysis requirements at subgroup analysis.
The kidney is the most severely affected organ in HFRS.
Tubular obstruction in the kidney, ischemic damage,
and immunological developing due to immune complex
accumulation occur together with direct hantavirusassociated injury in the kidneys [22]. As anticipated,
we therefore determined significantly higher serum
creatinine levels compared to the hantavirus-negative
group. Although no difference was determined between
the groups in terms of hepatic enzymes, LDH values were
higher, while ALP values were lower in the hantaviruspositive group. Due et al. [23] described AST levels as a
prognostic factor in predicting HFRS, while Zhenjun Yu
et al. [20] reported that LDH elevation was significant in
discriminating mild from severe HFRS. In their study of
hantavirus-positive and –negative patients, Kaya et al. [24]
determined no difference in ALT and values compared to
the control group; however, AST and LDH values were
higher in hantavirus-positive patients. Consistent with our
research, that study also observed no difference between
the two groups in terms of coagulation parameters.
Peripheral blood leucocyte ratios (NLR, PLR and
LMR) are novel, inexpensive, suitable for routine use,
and reproducible markers of the systemic inflammatory
response. They can be simply calculated from white
blood cell assay and determined under simple laboratory
conditions. The numbers of studies assessing the efficacy
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of NLR, PLR, and LMR in the diagnosis and prognosis
of various infectious diseases has continued to increase
in recent years [25-28]. We encountered no previously
published studies related to these parameters in hantavirus
disease.
PLR and LMR values were lower in our hantaviruspositive patient group, while NLR values were similar
between the two groups. Several studies have investigated
these parameters in viral or bacterial infections. One cohort
study of Crimean Congo Hemorrhagic Fever patients
in Turkey reported that a low PLR value was associated
with blood transfusion requirements and mortality [25].
However, we determined no relation between hantaviruspositive patients’ dialysis requirements and NLR, PLR, or
LMR. This may be due to our low patient number, and to
the fact that our cases involved the Puumala serotype with
its milder course. One study reported that low LMR was of
prognostic significance in confirming influenza virus and
severity of influenza in patients with influenza-like illness
[29]. Another study compared patients with Bell’s palsy
(BP), caused by the Herpes simplex virus, and a control
group, and reported high NLR values associated with poor
improvement in the BP [30]. The association between NLR
and outcomes of diabetic foot infection was examined
in a cohort of 75 patients. Higher NLR was observed in
patients who went on to develop osteomyelitis (mean 12.3
vs 6.0, P = 0.004) [31].
Limitations
There are a number of limitations to our study. First,
the cohort was small and the study was a single-center
one. Second, advanced analysis could not be performed
since no cut-off values could be calculated for laboratory
parameters in dialysis comparisons in hantavirus-positive
patients. Moreover, since the majority of our cases were
with Puumala serotype, our results may not be capable
of generalization to other serotypes. Further prospective,
extensive, randomized controlled studies will therefore
strengthen the present findings.
In conclusion, hantavirus infection continues to be
reported in Turkey, particularly in the north of the country.
Since the serotype involved in our region and surrounding
areas is generally Puumala, subclinical or milder infections
are generally involved. Variations in creatinine, LDH, and
platelet values in subjects presenting with hantavirus-like
symptoms, together with NLR, PLR, and LMR (peripheral
blood leucocyte ratios) will be of assistance to physicians
in the early diagnosis of hantavirus.
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